[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Health Agencies Update
April 25, 2007

FDA Advisor Conflicts

JAMA. 2007;297(16):1764. doi:10.1001/jama.297.16.1764-a

The Food and Drug Administration (FDA) proposed a new, tougher approach to conflicts of interest among advisors to the agency in March.

The FDA advisory committees, made up of experts on a particular topic, provide recommendations on actions the agency should take on drugs, medical devices, and other FDA-regulated products. The agency typically follows the advice of these panels. Previously, the agency had been criticized for allowing some members of the advisory panels to vote on recommendations that would benefit them financially, and for not having a consistent process for evaluating such conflicts.

First Page Preview View Large
First page PDF preview
First page PDF preview